Encouraging anti-tumour activity seen across all dose levels and in various tumour indications Clinical benefit rate of 80% ...
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...
44 th Annual J.P. Morgan Healthcare Conference Location: The Westin St. Francis Hotel, San Francisco, CA ...
Biomunex's CSO, Dr. Simon Plyte, is invited to present an oral communication during the 11th Annual Oncology Innovation Forum on the 10th of January 2026 in San Francisco (USA). -- The oral ...
Sandpipers Square Dance Club to hold square dance classes Start the new year dancing. On Thursday, Jan. 15 from 6:30 p.m.-9 p.m., at La Colonia Community Center, 715 Valley Avenue, Solana Beach, ...
Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 - -- Expects to initiate global Phase 1/2 MAD clinical study ...
ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
Delta's premium economy product is called Delta Premium Select, while United Airlines' equivalent is known as United Premium ...
Phrasing is "anything but objective," former Journal of the American Medical Association deputy editor says. Harvard-led ...
Do No Harm alleges Utah Department of Health and Human Services "systematic review" misleads on transgender outcomes.
Sound Point Meridian Capital Inc. remains a Buy despite a -35% price drop and -23% total return since December 2024. Click ...
Nearly one-quarter of adults with metabolic dysfunction-associated steatotic liver disease and cirrhosis presented before age ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback